Cargando…

Assessment of treatment interruption among pulmonary tuberculosis patients: A cross-sectional study

BACKGROUND: Multi-drug resistant tuberculosis (TB) is a rising peril of the TB control in India caused mostly by incomplete treatment. AIM: The aim was to assess the treatment interruption among pulmonary TB (PTB) patients. MATERIALS AND METHODS: A cross-sectional study was carried out for a period...

Descripción completa

Detalles Bibliográficos
Autores principales: Gorityala, Satya Bhgath, Mateti, Uday Venkat, Konuru, Venkateswarlu, Martha, Srinivas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4517326/
https://www.ncbi.nlm.nih.gov/pubmed/26229358
http://dx.doi.org/10.4103/0975-7406.160034
_version_ 1782383170270789632
author Gorityala, Satya Bhgath
Mateti, Uday Venkat
Konuru, Venkateswarlu
Martha, Srinivas
author_facet Gorityala, Satya Bhgath
Mateti, Uday Venkat
Konuru, Venkateswarlu
Martha, Srinivas
author_sort Gorityala, Satya Bhgath
collection PubMed
description BACKGROUND: Multi-drug resistant tuberculosis (TB) is a rising peril of the TB control in India caused mostly by incomplete treatment. AIM: The aim was to assess the treatment interruption among pulmonary TB (PTB) patients. MATERIALS AND METHODS: A cross-sectional study was carried out for a period of 9 months among PTB patients. Patients admitted with active pulmonary Koch's and history of anti-TB treatment (ATT) for 1-month or more from any source and who returns to treatment after not taking ATT consecutively for 2 months or more were included in the study. The data were collected from the patients or their caretakers to obtain the source of treatment given previously before default, number of treatment interruptions, phase and reasons for treatment interruption treatment. RESULTS: A total of 107 defaulters were identified during the study period. In the present study, 62.6% of the patients interrupted treatment only once, 55.34% of the patient's early continuation (3–4 months) treatment, and 47.66% of the patient's only one reason for the treatment interruptions during the course of the treatment. The most common reason for the treatment interruptions were felt well with TB treatment (29.53%) followed by side effects (16.06%), lack of money (8.29%), and other reasons. CONCLUSION: The study revealed that most of the defaulters were in the age group between 35 and 60 years, male gender, illiterates, daily wage labor, and married. The treatment interruptions were minimized by putting the efforts to improve direct supervision; pretreatment counseling and retrieve treatment interrupters were recommended.
format Online
Article
Text
id pubmed-4517326
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-45173262015-07-30 Assessment of treatment interruption among pulmonary tuberculosis patients: A cross-sectional study Gorityala, Satya Bhgath Mateti, Uday Venkat Konuru, Venkateswarlu Martha, Srinivas J Pharm Bioallied Sci Original Article BACKGROUND: Multi-drug resistant tuberculosis (TB) is a rising peril of the TB control in India caused mostly by incomplete treatment. AIM: The aim was to assess the treatment interruption among pulmonary TB (PTB) patients. MATERIALS AND METHODS: A cross-sectional study was carried out for a period of 9 months among PTB patients. Patients admitted with active pulmonary Koch's and history of anti-TB treatment (ATT) for 1-month or more from any source and who returns to treatment after not taking ATT consecutively for 2 months or more were included in the study. The data were collected from the patients or their caretakers to obtain the source of treatment given previously before default, number of treatment interruptions, phase and reasons for treatment interruption treatment. RESULTS: A total of 107 defaulters were identified during the study period. In the present study, 62.6% of the patients interrupted treatment only once, 55.34% of the patient's early continuation (3–4 months) treatment, and 47.66% of the patient's only one reason for the treatment interruptions during the course of the treatment. The most common reason for the treatment interruptions were felt well with TB treatment (29.53%) followed by side effects (16.06%), lack of money (8.29%), and other reasons. CONCLUSION: The study revealed that most of the defaulters were in the age group between 35 and 60 years, male gender, illiterates, daily wage labor, and married. The treatment interruptions were minimized by putting the efforts to improve direct supervision; pretreatment counseling and retrieve treatment interrupters were recommended. Medknow Publications & Media Pvt Ltd 2015 /pmc/articles/PMC4517326/ /pubmed/26229358 http://dx.doi.org/10.4103/0975-7406.160034 Text en Copyright: © Journal of Pharmacy and Bioallied Sciences http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Gorityala, Satya Bhgath
Mateti, Uday Venkat
Konuru, Venkateswarlu
Martha, Srinivas
Assessment of treatment interruption among pulmonary tuberculosis patients: A cross-sectional study
title Assessment of treatment interruption among pulmonary tuberculosis patients: A cross-sectional study
title_full Assessment of treatment interruption among pulmonary tuberculosis patients: A cross-sectional study
title_fullStr Assessment of treatment interruption among pulmonary tuberculosis patients: A cross-sectional study
title_full_unstemmed Assessment of treatment interruption among pulmonary tuberculosis patients: A cross-sectional study
title_short Assessment of treatment interruption among pulmonary tuberculosis patients: A cross-sectional study
title_sort assessment of treatment interruption among pulmonary tuberculosis patients: a cross-sectional study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4517326/
https://www.ncbi.nlm.nih.gov/pubmed/26229358
http://dx.doi.org/10.4103/0975-7406.160034
work_keys_str_mv AT gorityalasatyabhgath assessmentoftreatmentinterruptionamongpulmonarytuberculosispatientsacrosssectionalstudy
AT matetiudayvenkat assessmentoftreatmentinterruptionamongpulmonarytuberculosispatientsacrosssectionalstudy
AT konuruvenkateswarlu assessmentoftreatmentinterruptionamongpulmonarytuberculosispatientsacrosssectionalstudy
AT marthasrinivas assessmentoftreatmentinterruptionamongpulmonarytuberculosispatientsacrosssectionalstudy